scispace - formally typeset
Journal ArticleDOI

The Parkinson Progression Marker Initiative (PPMI)

TLDR
The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational, international, multi-center study designed to identify PD progression biomarkers both to improve understanding of disease etiology and course and to provide crucial tools to enhance the likelihood of success of PD modifying therapeutic trials.
About
This article is published in Progress in Neurobiology.The article was published on 2011-12-01. It has received 1269 citations till now.

read more

Citations
More filters
Journal ArticleDOI

VoxelMorph: A Learning Framework for Deformable Medical Image Registration

TL;DR: VoxelMorph promises to speed up medical image analysis and processing pipelines while facilitating novel directions in learning-based registration and its applications and demonstrates that the unsupervised model’s accuracy is comparable to the state-of-the-art methods while operating orders of magnitude faster.
Journal ArticleDOI

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

TL;DR: The spread of fibrillar α-synuclein pathology from the brainstem to limbic and neocortical structures seems to be the strongest neuropathological correlate of emerging dementia in Parkinson's disease.
Journal ArticleDOI

VoxelMorph: A Learning Framework for Deformable Medical Image Registration

TL;DR: Zhou et al. as mentioned in this paper proposed VoxelMorph, a fast learning-based framework for deformable, pairwise medical image registration, which parameterizes the function via a convolutional neural network and optimizes the parameters of the neural network on a set of images.
Journal ArticleDOI

Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

TL;DR: It is found that although different types of brain stimulation are applied in different locations, targets used to treat the same disease most often are nodes within the same brain network as defined by resting-state functional-connectivity MRI.
References
More filters
Journal ArticleDOI

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

TL;DR: This work proposes a model that relates disease stage to AD biomarkers in which Abeta biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegnerative biomarker become abnormal later, and correlate with clinical symptom severity.
Journal ArticleDOI

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

TL;DR: Deprenyl but not tocopherol delays the onset of disability associated with early, otherwise untreated Parkinson's disease and the action of deprenyl that accounts for its beneficial effects remains unclear.
Journal ArticleDOI

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

TL;DR: Ropinirole is associated with slower progression of PD than levodopa as assessed by 18F‐dopa PET, and this prospective, 2‐year, randomized, double‐blind, multinational study compared the rates of loss of dopamine‐terminal function in de novo patients with clinical and 18F-dopaPET evidence of early PD.
Related Papers (5)

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
Trending Questions (1)
Which organization started PPMI ?

The Parkinson Progression Marker Initiative (PPMI) was started by a partnership of government, PD foundations, industry, and academics.